Both in Surgical Instruments
Lucid Diagnostics vs Daxor
Over the past year LUCD returned −59.9% and DXR returned −34.0%; their daily moves had a correlation of 0.04.
LUCD −59.9% DXR −34.0%Growth of $1, one year, split-adjusted
| Metric | LUCD | DXR |
|---|---|---|
| Price | $0.4451 | $8.91 |
| Market cap | $85.0M | $52.0M |
| Today | +8.83% | +2.44% |
| 1 month | −25.8% | −13.5% |
| 6 months | −58.8% | −12.1% |
| Year to date | −59.2% | −39.6% |
| 1 year | −63.2% | — |
| Revenue growth (YoY) | +26.7% | +2.3% |
| Gross margin | 2.0% | 52.2% |
| Net margin | −998.3% | −403.2% |
| P/E (TTM) | — | — |
| Price / sales | 15.6× | — |
| Net cash | $9.9M | $18.7M |
| Dividend yield | — | — |
| Volatility (60d) | 109.9% | 43.0% |
| Short % of float | 8.7% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).